Pelthos Therapeutics (PTHS) Finished Goods (2025 - 2026)
Pelthos Therapeutics (PTHS) posted quarterly Finished Goods of $6.6 million for Q4 2025.
Pelthos Therapeutics (PTHS) Finished Goods (2025 - 2026) Analysis & Trends
Pelthos Therapeutics' Finished Goods history runs 1 years deep, the most recent figure standing at $6.6 million for Q4 2025.
- In Q4 2025, Finished Goods changed N/A year-over-year to $6.6 million; the TTM figure through Dec 2025 stood at $6.6 million (changed N/A YoY), while the FY2025 annual figure was $6.6 million, changed N/A from the prior year.
- Finished Goods for Q4 2025 stood at $6.6 million.
- The five-year high for Finished Goods was $6.6 million in Q4 2025, with the low at $6.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.90 Bn | 132.05 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.73 Bn | 60.55 Bn | 1.37 Bn |
| 4 | Moderna | 58.33 Bn | 53.19 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.72 Bn | 28.42 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.27 Bn | 9.88 Bn | 668.28 Mn |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.25 Bn | 26.41 Bn | - |
| 10 | Pelthos Therapeutics | 93.05 Mn | 68.49 Mn | 21.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.99 Mn |
| Dec 31, 2025 | 6.58 Mn |